Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy.
Graham J, Wells JC, Dudani S, Gan CL, Donskov F, Lee JL, Kollmannsberger CK, Meza L, Beuselinck B, Hansen A, North SA, Bjarnason GA, Sayegh N, Kanesvaran R, Wood LA, Hotte SJ, McKay RR, Choueiri TK, Heng DYC.
Graham J, et al. Among authors: dudani s.
Eur J Cancer. 2022 Aug;171:124-132. doi: 10.1016/j.ejca.2022.05.002. Epub 2022 Jun 16.
Eur J Cancer. 2022.
PMID: 35717820